Metadata

Dataset ID: 7
Back to List

Study Design
Study Design Background Inflammation assessment by in vivo PET and MRI of a Parkinson's disease model (MPTP) using the TSPO specific radiotracer [18F]VC701. Implementation of new tool analysis for mouse brain PET fully based on CT-images
Study Description Molecular and imaging prodromal markers of neurodegeneration in Parkinson disease
Study Type preclinical
Study Subtype in vivo
Publication
Paper Linked yes
Paper Title Development of a new toolbox for mouse PET-CT brain image analysis fully based on CT images and validated in a PD mouse model
Paper Authors Presotto L, Bettinardi V, Mercatelli D, Picchio M, Morari M, Moresco RM and Belloli S
Affiliation IBFM-CNR, University of Milano - Bicocca, IRCCS San Raffaele of Milan, University of Ferrara, Italy
Paper Journal Scientific reports
Paper Year 2022
Paper Doi https://doi.org/10.1038/s41598-022-19872-4
Open Access yes
Updated Year 2022
Study Component
Multi Modality Images yes
Imaging Modality PET/CT,MRI
Imaging Sub Modality T2w MRI
Radiation Yes
Imaging Coverage CT: head; PET: whole body
Imaging Target TSPO receptor activity
Dataset Information
Institution IBFM-CNR
Pi Moresco Rosa Maria
Co Pi Belloli Sara
Country Of Institution Italy
Imaging Facility Laboratory of molecular imaging for small animal
Euro Bio Imaging Node MMMI Italy
Country Of Imaging Facility Italy
In Vivo Experimental Parameters
Number Of Groups 1
Types Of Groups pre- e post-MPTP (1-metil 4-fenil 1,2,3,6-tetraidro-piridina) in a test-retest study
Overall Sample Size 6
Disease Model Parkinson's disease
Organ Or Tissue brain
Sample Size For Each Group 6 mice pre and post-treated with MPTP
Power Calculation none, pilot study
Randomization single group
Blinding no
Statistical Methods Student's t test for paired samples
Species Mice
Strain C57BL/6
Immune Status Immunocompetent
Sex Male
Age Three-month-old
Age At Start Experiment Three-month-old
Age At Scanning Experiment S Three-month-old
Weight About 30 g
Weight At Start Experiment About 30 g
Weight At End Experiment About 30 g
Source Of Animals University of Ferrara, Italy
Registry Number Of Animal Authorization 237/2019-PR
Experimental Procedures
Pharmacological Drug MPTP
Company MedChemExpress
Formulation solution from powder
Drug Dose 30
Volume 0,3
Concentration 100 mg/ml
Site Route Of Administration Intraperitoneally
Frequency Of Administration daily for 7 days
Vehicle Or Carrier Solution Formulation Saline
Drug Batch Sample Number Lot # 27361
Blood Sampling no
Surgical Procedures Including Sham Surgery no
Pathogen Infection Intervention And Control no
Analgesic Plan To Relieve Pain Suffering And Distress no
Anesthesia Type Gas
Duration 30
Anesthesia Drugs Isofluran
Anesthesia Dose 2% in 1L per minute/air mix
Monitoring Regime software remote control of the animal's vital functions (temperature, heartbeat and breathing)
Euthanasia yes
Method CO2 plus cervical dislocation
Histology no
Frequency Of Imaging Two time points
Timing Of Imaging Pre and post-MPTP treatment
Overall Scan Length 25 min for PET-CT and 70 min for MRI
Contrast Agent Or Radio Isotope Or Challenge With Gas Molecule Yes
Contrast Agent Commercial Drug [18F]VC701
Contrast Agent Chemical Drug Fluoromethyl derivative of PK11195
Contrast Agent Dose mean injected activity: 4,7 ± 0,3 MBq
Injection Volume 0,03
Injection Time scanning 100 min after radiotracer's injection
Vehicle saline
Route Of Administration intravenous
Image Acquisition
Instrument Vendor PET-CT Molecubes; MRI Bruker
Instrument Type β-Cube and X-Cube for PET and CT, respectively;Bruker Biospec 70/30 for MRI
Instrument Specifics PET: FOV of 72x130 mm; CT: FOV of 64x40 mm; 7Tesla MRI equipped with 450/675 mT/m gradients
Image Acquisition Parameters PET: 511 KeV, 30% energy resolution; CT: 40 kVp, 400 ?A (0.8 mm Al filtration)
Correction PET: isotope decay and random coincidences correction; CT: ring artifact correction
Raw Data Yes
Qa Qc Yes. PET: daily and mothly QC; CT: monthly QC; MRI: daily QC
Image Correlation
Image Type Reconstructed and quantified images
Image Scale KBq/cc for PET and HU for CT, T2 relaxation time for MRI
Format Compression raw, DICOM and NIFTI
Dimensions 2D/3D
Overall Number Of Images 1 dataset per animal per imaging technique per time point
Field Of View Max FOV for PET and CT, 14x15 mm for MRI
Dimension Extents PET: 192x192x384; MRI: 256x96x102
Size Description PET: 76.8 x 76.8 x 154 mm; MRI: 18,7 x 7 x 15 mm
Pixel Voxel Size Description PET: 400 µm isometric; MRI: 73 x 73 x 600 µm
Image Processing Methods CT-based normalization
Image Reconstruction Algorithm PET: OSEM (30 iterations); CT: ISRA (iterative).
Quality Control no
Image Registration Algorithm no
Ai Enhanced Algorithm no
Qc Info n/a
Corrections PET: acquisition decay, randoms; CT: none
Spatial And Temporal Alignment PET and CT images were automatically co-registered by the software; MR images were co-registered using CT
Fiducials Used Brain volume
Coregistered Images Yes
Transformation Matrix Other Info SPM coregistration
Analyzed Data
Analysis Result Type regional increase of radiotracer's uptake
Data Used For Analysis VOIs analysis, p value
Analysis Method And Details SPM, PMOD
Status complete
Ontology Terms
Ncit Imaging NCIT:C103512,NCIT:C16809
Ncit Imaging Submodality NCIT:C180729
Doid DOID:14330
Ncit Anatomy NCIT:C12439
Ncit Species NCIT:C14238
Ncit Strain NCIT:C14424
Chebi Pharmaco CHEBI:17963
Chebi Anesthesia CHEBI:6015
Back to List